about
From oligonucleotide shapes to genomic SELEX: novel biological regulatory loopsModified Nucleoside Triphosphates for In-vitro Selection TechniquesGeneration of Aptamers with an Expanded Chemical RepertoireNucleic acid aptamers: research tools in disease diagnostics and therapeuticsIn vitro selection using modified or unnatural nucleotidesSmart functional nucleic acid chimeras: enabling tissue specific RNA targeting therapyFit for the Eye: Aptamers in Ocular DisordersIn vitro selection using a dual RNA library that allows primerless selectionTechniques for molecular imaging probe designShort bioactive Spiegelmers to migraine-associated calcitonin gene-related peptide rapidly identified by a novel approach: tailored-SELEXTowards the selection of phosphorothioate aptamers optimizing in vitro selection steps with phosphorothioate nucleotides.Spiegelmers: biostable aptamers.Regulating eukaryotic gene expression with aptamers.Staining of cell surface human CD4 with 2'-F-pyrimidine-containing RNA aptamers for flow cytometryPreliminary nanopore cheminformatics analysis of aptamer-target binding strengthIsolation of virus-neutralizing RNAs from a large pool of random sequences.Peptide conjugation to an in vitro-selected DNA ligand improves enzyme inhibition.Nucleic acid aptamers: clinical applications and promising new horizonsArtificial specific binders directly recovered from chemically modified nucleic acid libraries.Functional tuning of nucleic acids by chemical modifications: tailored oligonucleotides as drugs, devices, and diagnostics.Nucleic Acid Ligands With Protein-like Side Chains: Modified Aptamers and Their Use as Diagnostic and Therapeutic AgentsRational truncation of an RNA aptamer to prostate-specific membrane antigen using computational structural modeling.In vitro evolution of chemically-modified nucleic acid aptamers: Pros and cons, and comprehensive selection strategiesIsolation of a nuclease-resistant decoy RNA that selectively blocks autoantibody binding to insulin receptors on human lymphocytes.Bioactive and nuclease-resistant L-DNA ligand of vasopressin.DNA-Catalyzed Amide HydrolysisHigh-affinity and specific recognition of human thyroid stimulating hormone (hTSH) by in vitro-selected 2'-amino-modified RNA.Evolution of thermophilic DNA polymerases for the recognition and amplification of C2'-modified DNA.In vitro selection using modified or unnatural nucleotides.Autocatalytic aptazymes enable ligand-dependent exponential amplification of RNA.Binding of a structured D-RNA molecule by an L-RNA aptamer.Application and analysis of structure-switching aptamers for small molecule quantification.Reflections of a Darwinian Engineer.Emerging affinity-based techniques in proteomics.Aptamers as targeted therapeutics: current potential and challenges.RNA ligands to human nerve growth factor.Anti-innexin 2 aptamers specifically inhibit the heterologous interaction of the innexin 2 and innexin 3 carboxyl-termini in vitro.DNA from bronchial secretions modulates elastase inhibition by alpha(1)-proteinase inhibitor and oxidized secretory leukoprotease inhibitor.Quality control certification of RNA aptamer-based detection.Biostable aptamers with antagonistic properties to the neuropeptide nociceptin/orphanin FQ.
P2860
Q24671006-5C4FFE38-57D4-4FD1-B953-6D082E258E96Q26747256-645D8D40-010B-4DED-B311-EF9CB19CAD3BQ26782794-1C6A9268-CCA7-490A-854E-8D54B82EBAF9Q26824321-4F36B57A-24C7-46DB-95CA-E81E34A21C3DQ26864079-B81444BF-346F-4A82-B985-881E5BEDC8ACQ27025832-AB9A706A-7AA4-4FFC-ADFD-2A0DF17DA78EQ28828283-90A1A7CA-E37E-4E44-A0F5-099961F04402Q29036552-51CB7642-5BD3-4D22-93D7-54DDB3CDE040Q30423734-329CA563-7870-4852-8322-85BF7228C9A1Q30823550-AB314B1B-AA26-4A90-9510-1DC1AA105A06Q30897436-6A118EEF-BABA-4861-B53D-5A77A43EA389Q31005222-4901D30E-216F-43EF-8F7D-602C3CEFD39CQ31067509-3425002D-5A4B-4EF0-A098-299EAB044EABQ32038821-F9C32D2F-2DF4-43CE-BEAF-AF152D4FE3F6Q33307838-C0AB114C-FB36-41A2-8500-05FC2366E4ACQ33704732-DA3B7843-A89A-4EF9-A5CF-70256A15BC3EQ33752349-1CAAF8D5-4B2D-4948-BF66-D29FE9B43489Q34028112-3117546D-E36B-4C5A-AD5C-C6067ECB9E15Q34456694-8D752FA9-A905-48C8-9B66-FE35852F80B9Q35054594-E4F05A7F-F99E-474A-97FD-88853E0DAFA1Q35309726-9530DDA7-14B5-4ACC-B27E-A8A52F148C36Q35413768-DEAB8DF1-B384-420B-88D3-484030DA9207Q36156320-5533E806-E2E6-4BAA-8680-648769619DFDQ36367219-B6D4548C-1402-4C90-839D-05BF343FCF1AQ36591985-FE41C8B0-611E-4407-89E9-91FF5978A280Q36619856-938BA737-AEF6-4769-9C1A-22FD1D3DE120Q36820144-DB97BB61-6325-4CF7-B5B4-872ABCBC8E4DQ36935996-F9D4BE1B-F0A8-4631-A889-4B438F9FA98CQ37144658-8CAF4A4F-E77B-4D29-A4C8-459A428807A1Q37226028-A3A0C68D-D34F-41B9-838C-DAC6B6F8CE29Q37245220-18CD47D5-E13D-48C8-BE3A-C0E8B4543F69Q37351674-720E354D-4CDA-4976-9E40-BA9234916C81Q37600648-84B57071-602E-4403-97B7-758C98B1A9F0Q37610324-3D8461AA-20E5-4C29-BF83-1FD0220ACCA6Q38290290-12635448-C4D1-474D-9412-529C655CCF50Q38292438-2673C724-190C-4640-ACF8-9D6AC28D7161Q38301069-CC4BB52D-AB0E-48B5-886A-F39C38BA4DA6Q38307876-BAF6ED22-ED88-4CAC-B204-18381B514428Q38316276-D796CF10-F8F3-46AA-B36E-3B380DE2897CQ38344663-F584951D-3E67-4516-82DE-B891DB3CD713
P2860
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Modified RNA sequence pools for in vitro selection.
@en
type
label
Modified RNA sequence pools for in vitro selection.
@en
prefLabel
Modified RNA sequence pools for in vitro selection.
@en
P2093
P2860
P356
P1476
Modified RNA sequence pools for in vitro selection.
@en
P2093
P2860
P304
P356
10.1093/NAR/22.24.5229
P577
1994-12-01T00:00:00Z